ERBB2 and breast cancer: To investigate the impact of various growth factors on the dynamic signaling response of cells derived from different breast cancer subtypes, we studied two cell lines of the luminal A subtype, T47D and MCF7, in addition to the triple-negative MDA-MB-231 and HER2-positive SKBR3 cell lines.